SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-23-006919
Filing Date
2023-05-25
Accepted
2023-05-25 16:18:15
Documents
13
Period of Report
2023-05-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_052523.htm   iXBRL 8-K 35590
2 PRESS RELEASE ex99-01.htm EX-99.1 13059
  Complete submission text file 0001387131-23-006919.txt   225633

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE tnxp-20230525.xsd EX-101.SCH 2968
4 XBRL LABEL FILE tnxp-20230525_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE tnxp-20230525_pre.xml EX-101.PRE 22365
7 EXTRACTED XBRL INSTANCE DOCUMENT tnxp-8k_052523_htm.xml XML 3471
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 23960805
SIC: 2834 Pharmaceutical Preparations